Get the Stockscreener App
3.65
0.27%
0.010
Galectin Therapeutics Inc stock is traded at $3.65, with a volume of 294.51K.
It is up +0.27% in the last 24 hours and up +64.41% over the past month.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
See More
Previous Close:
$3.64
Open:
$3.59
24h Volume:
294.51K
Relative Volume:
0.49
Market Cap:
$231.01M
Revenue:
-
Net Income/Loss:
$-45.08M
P/E Ratio:
-5.00
EPS:
-0.73
Net Cash Flow:
$-33.68M
1W Performance:
+25.43%
1M Performance:
+64.41%
6M Performance:
+192.00%
1Y Performance:
+63.31%
1-Day Range:
$3.575
$3.89
1-Week Range:
$2.88
$3.89
52-Week Range:
$0.726
$3.9035
Galectin Therapeutics Inc Stock (GALT) Company Profile
Name
Galectin Therapeutics Inc
Sector
Industry
Phone
678-620-3186
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Compare GALT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
3.65 | 230.38M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Resumed | H.C. Wainwright | Buy |
| Aug-13-20 | Reiterated | H.C. Wainwright | Buy |
| Feb-13-19 | Initiated | B. Riley FBR | Buy |
| Dec-07-17 | Reiterated | H.C. Wainwright | Buy |
| Nov-28-17 | Reiterated | H.C. Wainwright | Buy |
| Oct-19-17 | Initiated | ROTH Capital | Buy |
| Mar-30-17 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Oct-03-16 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| Sep-29-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-28-16 | Downgrade | ROTH Capital | Buy → Sell |
| Mar-28-16 | Resumed | H.C. Wainwright | Buy |
| Sep-21-15 | Initiated | H.C. Wainwright | Buy |
| Aug-01-14 | Downgrade | Aegis Capital | Buy → Hold |
| Jul-30-14 | Reiterated | MLV & Co | Buy |
| Jul-29-14 | Reiterated | MLV & Co | Buy |
| Apr-02-14 | Reiterated | MLV & Co | Buy |
| Feb-10-14 | Reiterated | Aegis Capital | Buy |
| Jan-09-14 | Reiterated | Aegis Capital | Buy |
| Dec-03-13 | Initiated | MLV & Co | Buy |
| Aug-19-13 | Reiterated | Aegis Capital | Buy |
View All
Galectin Therapeutics Inc Stock (GALT) Latest News
Strategies to average down on Galectin Therapeutics Inc.Chart Risk Profile for Capital Preservation - Newser
Is it time to cut losses on Galectin Therapeutics Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
Live market analysis of Galectin Therapeutics Inc.Predicted Market Direction Based on Momentum - Newser
Is Galectin Therapeutics Inc. a growth stock or a value stockTop Growth Planner That Work - jammulinksnews.com
Published on: 2025-08-01 00:21:52 - Newser
What the charts say about Galectin Therapeutics Inc. todayChart Confirmation Setup with ROI Signals - Newser
Price momentum metrics for Galectin Therapeutics Inc. explainedReal Chart Based Opportunity Identification - Newser
How does Galectin Therapeutics Inc. compare to its industry peersBreakout Stocks Watchlist That Work - jammulinksnews.com
Y Intercept Hong Kong Ltd Purchases New Shares in Galectin Therapeutics Inc. (NASDAQ:GALT) - MarketBeat
Earnings visualization tools for Galectin Therapeutics Inc.AI-Based Reversal Point Prediction Signal - Newser
How Galectin Therapeutics Inc. stock performs during market volatilityChart Risk Profile for Capital Preservation - Newser
What institutional investors are buying Galectin Therapeutics Inc. stockPre Market Target Finder For 2025 - jammulinksnews.com
Published on: 2025-07-30 21:20:45 - metal.it
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Y Intercept Hong Kong Ltd Takes Position in Galectin Therapeutics Inc. (NASDAQ:GALT) - Defense World
Combining price and volume data for Galectin Therapeutics Inc.Portfolio Review Summary with Five-Year Outlook - Newser
Does Galectin Therapeutics Inc. qualify in momentum factor screeningFree Weekly Growth Stock Entry Point Alerts - Newser
Published on: 2025-07-29 18:03:19 - metal.it
Published on: 2025-07-29 17:22:41 - metal.it
Published on: 2025-07-29 06:30:28 - Newser
What makes Galectin Therapeutics Inc. stock price move sharplyFree Daily Momentum Screener With Alerts - Newser
What catalysts could drive Galectin Therapeutics Inc. stock higher in 2025Low Risk Report For Consistent Profits - jammulinksnews.com
How volatile is Galectin Therapeutics Inc. stock compared to the marketAchieve rapid returns with smart investment plans - jammulinksnews.com
Is Galectin Therapeutics Inc. stock overvalued or undervaluedCapitalize on emerging market opportunities - jammulinksnews.com
Why Galectin Therapeutics Inc. stock attracts strong analyst attentionChart Pattern Strategy with ROI Focus - Newser
Is it time to cut losses on Galectin Therapeutics Inc. Free Value Investing Picks With Stability - Newser
What are Galectin Therapeutics Inc. company’s key revenue driversMarket-beating returns - jammulinksnews.com
What are the latest earnings results for Galectin Therapeutics Inc.Swing Trade Tips For Consistent Profits - jammulinksnews.com
What is the risk reward ratio of investing in Galectin Therapeutics Inc. stockFree Risk Assessment Services - jammulinksnews.com
What are analysts’ price targets for Galectin Therapeutics Inc. in the next 12 monthsBuild a balanced portfolio for long-term success - jammulinksnews.com
How strong is Galectin Therapeutics Inc. company’s balance sheetCapitalize on proven investment strategies - jammulinksnews.com
What are the technical indicators suggesting about Galectin Therapeutics Inc.Get ahead with breakthrough trading ideas - jammulinksnews.com
Top Risks to Consider Before Buying Galectin Therapeutics Inc. StockFree Market Dynamics Reports - Newser
Galectin Therapeutics Inc Stock (GALT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):